Axolabs is a leading custom research organisation providing high-end solutions and consultancy in the field of oligonucleotide therapeutics and nucleic acid medicines. Founded firmly on our world-leading know-how with more than 20 years of experience, we provide high-end preclinical and clinical development solutions tailored to our client’s needs.

As a one-stop-shop we provide efficient and validated services towards the successful development of oligonucleotide-based therapeutics. We deliver integrated solutions for preclinical research and clinical development covering chemistry, biology, bio-analytics, analytics and manufacturing, including manufacturing capabilities for oligonucleotide drug substance under the standards of GMP at our branches in Petaluma and Berlin.